{"transactions":[{"id":2043939,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":117604,"kind":"person","name":"MODUR VIJAY","position":1,"cik":"0001854082","reported_name":"MODUR VIJAY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-01-27T21:02:53.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of January 25, 2023, and the remaining 75% of the underlying shares vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date."}],"balance_after":30000,"derivative":{"exercise_price":4.27,"expiration_date":"2033-01-25","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-23-007510","document":"tm234565-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465923007510/tm234565-1_4seq1.xml","form_type":"4"}},{"id":2486678,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":117604,"kind":"person","name":"MODUR VIJAY","position":1,"cik":"0001854082","reported_name":"MODUR VIJAY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Restricted Stock Units","published_at":"2021-12-03T22:14:26.000Z","date":"2021-12-01","kind":"exercise","acquired":false,"shares":219326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":219326},"source":{"system":"sec-edgar","filing":"0001415889-21-005692","document":"form4-12032021_021220.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921005692/form4-12032021_021220.xml","form_type":"4"}},{"id":2486677,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":117604,"kind":"person","name":"MODUR VIJAY","position":1,"cik":"0001854082","reported_name":"MODUR VIJAY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Common Stock","published_at":"2021-12-03T22:14:26.000Z","date":"2021-12-01","kind":"tax_withholding","acquired":false,"shares":64373,"price":0.72,"value":46348.56,"ownership":{"direct":true},"balance_after":154953,"source":{"system":"sec-edgar","filing":"0001415889-21-005692","document":"form4-12032021_021220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921005692/form4-12032021_021220.xml","form_type":"4"}},{"id":2486676,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":117604,"kind":"person","name":"MODUR VIJAY","position":1,"cik":"0001854082","reported_name":"MODUR VIJAY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Common Stock","published_at":"2021-12-03T22:14:26.000Z","date":"2021-12-01","kind":"exercise","acquired":true,"shares":219326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock."}],"balance_after":219326,"source":{"system":"sec-edgar","filing":"0001415889-21-005692","document":"form4-12032021_021220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921005692/form4-12032021_021220.xml","form_type":"4"}},{"id":2708658,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":117604,"kind":"person","name":"MODUR VIJAY","position":1,"cik":"0001854082","reported_name":"MODUR VIJAY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-05-18T21:48:03.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":496204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan in accordance with the anti-dilution provisions of the Reporting Person's employment agreement in connection with a Qualifying Financing as defined therein. The stock options vest and become exercisable over the four-year period commencing April 1, 2021, with one-fourth of the shares of common stock underlying the options vesting on April 1, 2022, and the remainder vesting in twelve equal quarterly installments thereafter, subject to Reporting Person's continued employment or other service with the Issuer on each applicable vesting date, which vesting may be accelerated in connection with certain qualifying terminations of employment or in connection with a corporate transaction."}],"balance_after":496204,"derivative":{"exercise_price":1.41,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":496204},"source":{"system":"sec-edgar","filing":"0001415889-21-002555","document":"form4-05182021_020547.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921002555/form4-05182021_020547.xml","form_type":"4"}},{"id":2762110,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":117604,"kind":"person","name":"MODUR VIJAY","position":1,"cik":"0001854082","reported_name":"MODUR VIJAY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-04-03T01:00:39.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":711619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan. The stock options vest and become exercisable over a four-year period, with one-fourth of the Issuer's shares of common stock underlying the options vesting on April 1, 2022, and with the remainder vesting in twelve equal quarterly installments thereafter, subject to Reporting Person's continued employment or other service with the Issuer on each applicable vesting date, which vesting may be accelerated in connection with certain qualifying terminations of employment or in connection with a corporate transaction."}],"balance_after":711619,"derivative":{"exercise_price":3.36,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":711619},"source":{"system":"sec-edgar","filing":"0001415889-21-001849","document":"form4-04022021_060425.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921001849/form4-04022021_060425.xml","form_type":"4"}},{"id":2762109,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":117604,"kind":"person","name":"MODUR VIJAY","position":1,"cik":"0001854082","reported_name":"MODUR VIJAY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Restricted Stock Units","published_at":"2021-04-03T01:00:39.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":44683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan and will vest in full on December 1, 2021, subject to the Reporting Person's continued employment or other service with the Issuer, which vesting may be accelerated in connection with certain qualifying terminations of employment or in connection with a corporate transaction. Promptly following vesting, and in any event on or prior to December 31, 2021, each restricted stock unit will be settled by delivery of one share of the Issuer's common stock to the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan and will vest in full on December 1, 2021, subject to the Reporting Person's continued employment or other service with the Issuer, which vesting may be accelerated in connection with certain qualifying terminations of employment or in connection with a corporate transaction. Promptly following vesting, and in any event on or prior to December 31, 2021, each restricted stock unit will be settled by delivery of one share of the Issuer's common stock to the Reporting Person."}],"balance_after":219326,"derivative":{"underlying":"Common Stock","underlying_shares":44683},"source":{"system":"sec-edgar","filing":"0001415889-21-001849","document":"form4-04022021_060425.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921001849/form4-04022021_060425.xml","form_type":"4"}},{"id":2762108,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":117604,"kind":"person","name":"MODUR VIJAY","position":1,"cik":"0001854082","reported_name":"MODUR VIJAY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"HEAD OF R&D"}}],"security":"Restricted Stock Units","published_at":"2021-04-03T01:00:39.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":174643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan and will vest in full on December 1, 2021, subject to the Reporting Person's continued employment or other service with the Issuer, which vesting may be accelerated in connection with certain qualifying terminations of employment or in connection with a corporate transaction. Promptly following vesting, and in any event on or prior to December 31, 2021, each restricted stock unit will be settled by delivery of one share of the Issuer's common stock to the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan and will vest in full on December 1, 2021, subject to the Reporting Person's continued employment or other service with the Issuer, which vesting may be accelerated in connection with certain qualifying terminations of employment or in connection with a corporate transaction. Promptly following vesting, and in any event on or prior to December 31, 2021, each restricted stock unit will be settled by delivery of one share of the Issuer's common stock to the Reporting Person."}],"balance_after":174643,"derivative":{"underlying":"Common Stock","underlying_shares":174643},"source":{"system":"sec-edgar","filing":"0001415889-21-001849","document":"form4-04022021_060425.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921001849/form4-04022021_060425.xml","form_type":"4"}}]}